Deep Brain Stimulation May Rewire the Brain: New Evidence of White Matter Remodeling


By Joao L. de Quevedo, MD, PhD, Director, Center for Interventional Psychiatry UTHealth Houston
June 25, 2026

For years, clinicians have observed a fascinating phenomenon in patients receiving deep-brain stimulation (DBS) for treatment-resistant depression. While some changes occur rapidly, the full antidepressant benefits often emerge gradually over weeks or months.

Why does this happen?

A groundbreaking study recently published in Nature Neuroscience offers a compelling answer: DBS may not only change how brain circuits function—it may actually help remodel the brain’s wiring.

Looking Beyond Electrical Stimulation

Deep brain stimulation has become an important treatment option for individuals with severe neurological and psychiatric disorders that have not responded to conventional therapies.

In treatment-resistant depression, DBS commonly targets a region known as the subcallosal cingulate cortex (SCC), a critical hub involved in mood regulation. Previous studies have demonstrated that stimulating white matter pathways near this region can produce long-term improvement in approximately 60–75% of carefully selected patients with severe depression.

Until now, however, scientists have not fully understood how DBS produces these sustained clinical effects.

Most theories have focused on immediate changes in neuronal firing and network activity. The new study suggests that a second process may be equally important: structural remodeling of white matter pathways.

What Is White Matter?

The brain consists of two major components:

  • Gray matter, which contains neuronal cell bodies
  • White matter, which contains the connections that allow brain regions to communicate with one another

White matter fibers are wrapped in a fatty insulating material called myelin, which helps electrical signals travel quickly and efficiently throughout the brain.

Many neuroimaging studies have shown abnormalities in white matter connectivity in major depressive disorder, particularly in individuals with treatment-resistant depression.

The question has been whether successful treatments can restore these connections.

A Unique Study Design

To answer this question, researchers implanted DBS electrodes in nonhuman primates at the same target used in human depression treatment studies: the white matter crossroads where the cingulum bundle, forceps minor, and uncinate fasciculus converge. Animals then received six weeks of continuous stimulation using clinical DBS parameters.

The investigators combined advanced neuroimaging, histology, electron microscopy, and functional MRI to examine both structural and functional brain changes.

This multimodal approach allowed them to examine the brain from large-scale networks down to individual myelin sheaths.

DBS Increased White Matter Integrity

One of the most striking findings was a selective increase in fractional anisotropy (FA) within the cingulum bundle. FA is a widely used MRI measure associated with white matter integrity and organization.

Importantly, these changes occurred not directly at the stimulation site but in a more distant portion of the cingulum bundle connecting the subcallosal cingulate with dorsal and posterior cingulate regions.

This suggests that DBS may trigger adaptive changes throughout an entire neural circuit rather than affecting only the tissue immediately surrounding the electrode.

Evidence of New Myelin Formation

Perhaps the most exciting aspect of the study came from the microscopic analyses.

The investigators found:

  • Increased numbers of mature myelinating oligodendrocytes
  • Greater myelin thickness surrounding axons
  • Structural evidence of enhanced white matter organization

In other words, the imaging findings were supported by direct biological evidence that DBS promoted myelin remodeling.

This is important because myelin influences the speed and synchronization of communication between brain regions.

Improved myelination could help restore the efficiency of neural networks that are disrupted in depression.

DBS Changed Brain Networks

The study also demonstrated widespread changes in functional connectivity across the brain. While structural changes were concentrated within the cingulum bundle, functional effects extended across multiple large-scale networks.

The most prominent changes involved:

  • The Default Mode Network (DMN)
  • The Limbic Network
  • The Central Executive Network
  • Components of the Salience Network

These networks are heavily implicated in depression and are involved in self-referential thinking, emotional processing, attention, and cognitive control.

After chronic stimulation, connectivity between the subcallosal cingulate and several regions within these networks decreased, suggesting a normalization of maladaptive communication patterns.

Why This Matters for Depression

Depression is increasingly understood as a disorder of dysfunctional brain circuits rather than a simple imbalance of neurotransmitters.

This study supports that modern view.

The findings suggest that DBS may work through two complementary mechanisms:

  1. Rapid functional modulation of abnormal neural activity
  2. Gradual structural remodeling of white matter pathways

The second mechanism may help explain why sustained clinical improvement often develops over time and can remain durable for years in some patients receiving ongoing DBS therapy.

Implications for the Future of Interventional Psychiatry

Although this study was performed in nonhuman primates rather than patients with depression, the implications are substantial.

The findings raise several important possibilities:

  • White matter plasticity may be a therapeutic target in depression.
  • Future neuromodulation treatments could be optimized to promote myelin remodeling.
  • Neuroimaging biomarkers may help identify patients most likely to benefit from DBS.
  • Similar mechanisms may contribute to the therapeutic effects of other neuromodulation approaches.

As our understanding of brain circuits continues to evolve, treatments may increasingly focus not only on changing neural activity but also on repairing and strengthening the structural connections that support healthy brain function.

The UTHealth Houston Perspective

At the Center for Interventional Psychiatry at UTHealth Houston, we view studies like this as part of a broader shift in psychiatry toward circuit-based medicine.

Modern treatments such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), ketamine, and deep brain stimulation increasingly target dysfunctional neural networks rather than isolated symptoms.

This study provides some of the strongest evidence to date that neuromodulation can induce measurable biological changes in the brain’s structural wiring.

While additional research is needed to confirm these mechanisms in patients, the findings bring us one step closer to understanding how advanced neuromodulation therapies achieve lasting clinical benefit.

Reference

Fujimoto SH, Fujimoto A, Elorette C, et al. Deep brain stimulation induces white matter remodeling and functional changes to brain-wide networks. Nature Neuroscience. 2026. DOI: 10.1038/s41593-026-02301-4.

Contact

Request for Second Opinion Form – https://Go.uth.edu/CIPIntake (external link)
Phone – (713) 486-2621
Fax – (713) 500-2728
E-mail – [email protected]
Website – https://go.uth.edu/CIP (external link)

Disclaimer

This article discusses findings from a recently published scientific study and is intended for educational and informational purposes only. The findings described were derived from preclinical research conducted in nonhuman primates and should not be interpreted as direct evidence of clinical efficacy in humans. Additional research is needed to determine how these mechanisms translate to patients with psychiatric disorders.

This article was created with the assistance of artificial intelligence (AI) to help organize and refine the presentation of scientific information. All medical and scientific content has been reviewed and approved by Joao L. de Quevedo, MD, PhD, Executive Director of the Center for Interventional Psychiatry at the John S. Dunn Behavioral Sciences Center at UTHealth Houston.

The content is not intended to provide medical advice, diagnosis, or treatment recommendations. Individuals experiencing symptoms of depression or other psychiatric conditions should seek evaluation from a qualified healthcare professional.